Aptevo Therapeutics Inc.

APVO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 33 employees
264
SEC Filings
$1.28
Close 2026-10-27
33
Employees

Business Summary

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapy candidates for cancer treatment. The company operates two proprietary platforms, ADAPTIR and ADAPTIR-FLEX, for designing multi-specific antibody candidates. Its pipeline includes two clinical candidates—mipletamig (CD123xCD3 bispecific for AML) and ALG.APV-527 (4-1BBx5T4 bispecific for solid tumors)—plus six preclinical candidates targeting hematologic malignancies and solid tumors.

Latest Stock Quote

APVO 2026-10-27 $1.28 O:$1.55 H:$1.58 L:$1.2525 Vol:0.1M VWAP:$1.3301
origin leaf: null

Next Earnings

expected 2026-12-24

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126278EDGAR83K words
2025-02-142024-12-310000950170-25-020467EDGAR83K words
2024-03-052023-12-310000950170-24-025428EDGAR82K words
2023-03-302022-12-310000950170-23-010757EDGAR71K words
2022-03-242021-12-310001564590-22-011575EDGAR68K words
2021-03-312020-12-310001564590-21-016875EDGAR65K words
2020-03-252019-12-310001564590-20-012791EDGAR53K words
2019-03-182018-12-310001564590-19-008184EDGAR62K words
2018-03-132017-12-310001564590-18-005384EDGAR58K words
2017-03-312016-12-310001564590-17-005738EDGAR72K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-162026-09-300001193125-26-462265EDGAR—
2026-08-142026-06-300001193125-26-350559EDGAR46K words
2025-11-062025-09-300001193125-25-269598EDGAR44K words
2025-08-112025-06-300000950170-25-106247EDGAR45K words
2025-05-152025-03-310000950170-25-072622EDGAR42K words
2024-11-072024-09-300000950170-24-122837EDGAR46K words
2024-08-082024-06-300000950170-24-093366EDGAR44K words
2024-05-082024-03-310000950170-24-055096EDGAR41K words
2023-11-142023-09-300000950170-23-063379EDGAR49K words
2023-08-102023-06-300000950170-23-040983EDGAR47K words
2023-05-112023-03-310000950170-23-020870EDGAR45K words
2022-11-102022-09-300001564590-22-037287EDGAR49K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-160001193125-26-462254EDGAR2K words
2026-11-120001193125-26-458751EDGAR1K words
2026-11-090001193125-26-452737EDGAR2K words
2026-11-050001193125-26-448714EDGAR2K words
2026-11-020001193125-26-442031EDGAR1K words
2026-10-260001193125-26-431079EDGAR1K words
2026-10-230001193125-26-430419EDGAR1K words
2026-10-140001193125-26-421076EDGAR1K words
2026-09-240001193125-26-400213EDGAR1K words
2026-09-230001193125-26-399545EDGAR1K words

264 total filings indexed. 232 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

hematologic-malignancies-(aml) solid-tumor-oncology cancer-immunotherapy bispecific-antibody-therapeutics adaptir-platform adaptir-flex-platform cris-7-cd3-binding-domain

Company Identity

CIK0001671584
TickerAPVO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.aptevotherapeutics.com
Listed2016-07-20

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 61669ad594e5af968155b15d9f16faab14b79852eed7ace2ea661645b44c8630
parent: d7a1e0372df6c8e5dc92c60aadb376c6b0dfac8c2706210e190b9c370661b9c1
content hash: 059b26de309478336c349e477d23223686a991caa40db59aa0d2860ddae6db4e
signed: 2026-11-16T19:00:40.150Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up APVO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on APVO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/APVO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.